Patent ID: 7696236

Claim:
A method of providing pirfenidone therapy to a patient for the treatment of idiopathic pulmonary fibrosis in an initial dose escalation regimen, comprising: providing pirfenidone to a patient at a first oral daily dosage of 801 mg as one capsule comprising 267-mg of pirfenidone three times a day for days one to seven of the dose escalation regimen; providing a second oral daily dosage of 1602 mg as two capsules comprising 267-mg of pirfenidone three times a day for days eight to fourteen of the dose escalation regimen; providing a third oral daily dosage of 2403 mg as three capsules comprising 267-mg of pirfenidone three times a day for at least day fifteen of the dose escalation regimen; and instructing said patient to take said dosages with food, wherein the patient is provided pirfenidone for the treatment of idiopathic pulmonary fibrosis.